Patna: The state commercial taxes department on Wednesday notified the reduction of GST on three medicines—Tratstuzumab Daruxtecan, Onimartinib and Durvalumab—used for the treatment of cancer, and also on extruded salty items. It also freed govt undertakings, research associations, colleges and institutions which conduct research and development with govt or private grant under Section 36 of the IT Act, from the GST.
With a view to preventing tax theft in the trade of scrap metal, the department has also notified the payment of tax by the non-registered and registered persons who deal in the sale and purchase of scrap metal.
While the GST reduction has been done in line with the decisions taken at the 54th meeting of the GST council, the notifications issued would become effective from Thursday, a communiqué by IPRD on Wednesday said.
The GST on the three medicines used in the treatment of cancer has been reduced from 12% to 5%.
New GST rules effective from October 10 mandate registered tenants of non-registered commercial property owners to pay 18% GST under reverse charge mechanism (RCM). This change affects small businesses, particularly those under the composition scheme, leading to increased working capital requirements as input tax credits cannot be claimed. Experts highlight the challenges faced by lessees in this scenario.
A magisterial court in Ahmedabad has remanded four individuals, including journalist Mahesh Langa, to 10 days of custodial interrogation for alleged GST fraud involving fake firms and fraudulent input tax credit. The crime branch cited significant financial losses to the country, with the investigation uncovering cash and alleged misuse of contacts for financial gain.
An iron trader from Meerut, Akshat Jain, began a 580km foot march to UP CM Yogi Adityanath, protesting alleged harassment and a Rs 1 lakh bribe demand by GST officials to release a seized vehicle. A video of Jain’s dramatic protest surfaced online, sparking controversy. GST officials denied the claims and lodged a police complaint against him.
